Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17

Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 in Europe Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been recommended for…

thaipr.net

24 มิ.ย. 65

FARO’s HoloBuilder™ Construction Progress Management Solution Gains Widespread Adoption

—1 Year Post Acquisition, GOLDBECK ‘Enterprise’ Agreement Represents Textbook Example— FARO® Technologies, Inc. (Nasdaq: FARO), a global leader in 4D digital reality solutions, today formally recognized the #Enterprise agreement by GOLDBECK to deploy FARO’s HoloBuilder Construction Progress Management solution enterprise-wide as indicative of the healthy market adoption of HoloBuilder following the company’s acquisition…

thaipr.net

24 มิ.ย. 65

Open access publisher Hindawi makes detailed publishing metrics publicly available

Hindawi Limited announces the launch of new journal reports, which provide unprecedented detail about the underlying services of Hindawi’s journals. Hindawi’s journal reports showcase a wide range of publishing metrics, from submission through peer review and discovery – providing greater than ever insight into the performance and makeup of their journals. The reports were created in […]

thaipr.net

24 มิ.ย. 65
1 2,335 2,336 2,337 2,338 2,339 3,458